Endogenous opioid peptides: multiple agonists and receptors
The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
Opioid peptides were assayed by inhibition of 3H-naloxone and 3H-leu-enkephalin binding in brain homogenates and by depression of contractions of the guinea pig ileum and mouse vas deferens. We conclude that the opioid peptidergic system has agonists of different characteristics which interact with more than one type of receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher order brain regions (PFC; rACC) project to the PAG, the rostral ventral medulla, and the dorsal horn of the spinal cord to reduce the elaboration of spinal and supraspinal nociceptive processing through the release of endogenous opioids9,77,78 that largely bind with mu, delta, and kappa receptors.54,69”
From The neural mechanisms of mindfulness-based pain relief: a functional magnetic resonance imaging-based review and primer (2019) · cites this paper as [69]
Citations
Cites
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Self-citationMartin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Opiate Receptor: Demonstration in Nervous Tissue
Pert, C. B., & Snyder, S. H. (1973) · Science · doi:10.1126/science.179.4077.1011 · Cited by 2,388
Opiates and endogenous opioid peptides
Kelly, J. S., & Dingledine, R. (1977) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(77)90262-6 · Cited by 1,282
Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate
Simon, E. J., Hiller, J. M., & Edelman, I. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.1947 · Cited by 1,067
Elde, R., Hökfelt, T., Johansson, O., & Terenius, L. (1976) · Neuroscience · doi:10.1016/0306-4522(76)90063-4 · Cited by 775
C fragment of lipotropin has a high affinity for brain opiate receptors
BRADBURY, A. F., SMYTH, D. G., SNELL, C. R., BIRDSALL, N. J. M., & HULME, E. C. (1976) · Nature · doi:10.1038/260793a0 · Cited by 489
Gilbert, P. E., & Martin, W. R. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30572-0 · Cited by 487
Choline esters in tissue extracts
Chang, H. C., & Gaddum, J. H. (1933) · The Journal of Physiology · doi:10.1113/jphysiol.1933.sp003049 · Cited by 486
[D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide Analgesic
Pert, C. B., Pert, A., Chang, J.-K., & Fong, B. T. (1976) · Science · doi:10.1126/science.968485 · Cited by 469
Research works printed but not linked: 14
- Guillemin, R., Ling, N. & Burgus, R. C. r. hebd. Sèanc. Acad. Sci., Paris D274, 783–785 (1976).
- Waterfield, A. A., Smokcum, R. W. J., Hughes, J., Kosterlitz, H. W. & Henderson, G. Eur. J. Pharmac. (in the press).
- Martin, W. R., Pharmac Rev. 19, 463–521 (1967).
- Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. & Gilbert P. E. J. Pharmac. exp. Ther. 197, 517–532 (1976).
- Gilbert, P. E. & Martin, W. R. J. Pharmac. exp. Ther. 198, 66–82 (1976).
- Kosterlitz, H. W. & Watt, A. J. Br. J. Pharmac. 33, 266–276 (1968).
- Martin, W. R., Bell, J. A., Gilbert, P. E., Sloan, J. W. & Thompson, J. A. in Narcotic Antagonists: Naltrexone. NIDA Research Monograph 9 (ed. Julius, D & Renault, P.) 27–30 (Department of Health, Education and Welfare, Washington, D.C., 1976).
- Feldberg, W. & Smyth, D. G. J. Physiol., Lond. 260, 30P–31P (1976); 265, 25P–27P (1977).
- Pert, A. in Opiates and Endogenous Opioid Peptides(ed. Kosterlitz, H. W.) 87–94 (North-Holland, Amsterdam, 1976).
- Arunlakshana, O. & Schild, H. O. Br. J. Pharmac. 14, 48–58 (1959).
- Creese, I. & Snyder, S. H. J. Pharmac. exp. Ther. 194, 205–219 (1975).
- Simantov, R. & Snyder, S. H. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 41–48 (North-Holland, Amsterdam, 1976).
- Smith, T. W., Hughes, J., Kosterlitz, H. W. & Sosa, R. P. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 57–62 (North-Holland, Amsterdam, 1976).
- Simantov, R., Kuhar, M. J. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. (in the press).
Cited by
Items 601–700 of 1,002
Arjune, D., Bowen, W. D., & Bodnar, R. J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90203-e · Cited by 54
[3H]Tyr-D-Ser-Gly-Phe-Leu-Thr: A specific probe for the δ-opiate receptor subtype in brain membranes
David‐Dufilho, M., Moisand, C., Meunier, J., Morgat, J. L., Gacel, G., & Roques, B. P. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90046-2 · Cited by 54
Natural Products as Leads for New Pharmaceuticals
Buss, A. D., Cox, B. J., & Waigh, R. D. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc018 · Cited by 54
Visualization and solubilization of rat brain opiate receptors with a ??? ligand selectivity pattern
Quirion, R., Bowen, W. D., Herkenham, M. A., & Pert, C. B. (1982) · Cellular and Molecular Neurobiology · doi:10.1007/bf00710853 · Cited by 54
“After the discovery of the enkephalins (Hughes et al., 1975), Lord et al. (1977) observed a ligand selectivity pattern in a mouse vas deferens bioassay (opiate peptides more potent than morphine) which was sufficiently different from that of the guinea pig ileum ("#") for a new opiate receptor class, called "b" (for d…”
BackgroundOpioid Receptor Interacting Proteins and the Control of Opioid Signaling
Lamberts, J. T., & Traynor, J. R. (2014) · Current Pharmaceutical Design · doi:10.2174/138161281942140105160625 · Cited by 52
“Shortly thereafter, three distinct opioid receptor types were identified based on physiological observations; each receptor was named after the drug or assay system with which it was characterized: the μ receptor for morphine, the κ receptor for ketocyclazocine [7], and the δ receptor for the mouse vas deferens [8].”
BackgroundHau, V. S., Huber, J. D., Campos, C. R., Lipkowski, A. W., Misicka, A., & Davis, T. P. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10202 · Cited by 53
Vansteensel, M. J., Magnone, M. C., van Oosterhout, F., Baeriswyl, S., Albrecht, U., Albus, H., Dahan, A., & Meijer, J. H. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04131.x · Cited by 59
“Naloxone blocks l-, d, and j-opioid receptors (Lord et al., 1977; Minami & Satoh, 1995) and effectively renders the preparation into a pharmacological opioid receptor knockout animal (Dahan et al., 2001).”
BackgroundThe effect of norbinaltorphimine, β-funaltrexamine and naltrindole on NPY-induced feeding
Kotz, C. M., Grace, M. K., Billington, C. J., & Levine, A. S. (1993) · Brain Research · doi:10.1016/0006-8993(93)91552-4 · Cited by 53
Proceedings of the British Pharmacological Society
Towart, R., & Kazda, S. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb08695.x · Cited by 53
Miller, R. J., & Cuatrecasas, P. (1979) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60987-5 · Cited by 58
Long term ethanol alters the binding of 3H-opiates to brain membranes
Gianoulakis, C. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90777-4 · Cited by 54
Chronic ethanol imbibition interferes with δ-, but not with μ-opiate receptors
Pfeiffer, A. F. H., Seizinger, B. R., & Herz, A. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90070-8 · Cited by 53
Beani, L., Bianchi, C. L., & SINISCALCHI, A. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09233.x · Cited by 53
Opioid Peptides and Blood Pressure Regulation
Lang, R. E., Brückner, U. B., Kempf, B., Rascher, W., Sturm, V. J. F., Unger, T., Speck, G., & Ganten, D. (1982) · Clinical and Experimental Hypertension · doi:10.3109/10641968209061589 · Cited by 53
Multiple membrane actions of enkephalin revealed using cultured spinal neurons
Barker, J. L., Smith, T. G., & Neale, J. H. (1978) · Brain Research · doi:10.1016/0006-8993(78)91063-6 · Cited by 52
Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat
Moises, H. C., & Walker, J. M. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90286-9 · Cited by 53
Khan, M. I. H., Sawyer, B. J., Akins, N. S., & Le, H. V. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114785 · Cited by 57
Wang, Y., Xing, Y., Liu, X., Ji, H., Kai, M., Chen, Z., Yu, J., Zhao, D., Ren, H. J., & Wang, R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300664y · Cited by 54
Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys
DANIELSSON, I., Ga̧sior, M., Stevenson, G. W., FOLK, J., Rice, K. C., & Negus, S. S. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.012 · Cited by 59
“delta, mu and kappa opioid receptors) (Martin et al., 1976; Lord et al., 1977; Kieffer, 1995).”
BackgroundThe opiate system in invertebrates
Harrison, L. M., Kastin, A. J., Weber, J. T., Banks, W. A., Hurley, D. L., & Zadina, J. E. (1994) · Peptides · doi:10.1016/0196-9781(94)90159-7 · Cited by 52
Hazum, E., Chang, K., Leighton, H. J., Lever, O. W., & Cuatrecasas, P. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91981-7 · Cited by 52
Effects of naloxone and diprenorphine on spontaneous activity in rats and mice
DeRossett, S. E., & Holtzman, S. G. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90090-9 · Cited by 52
Faden, A. I., & Feuerstein, G. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb10547.x · Cited by 52
Opiate activity and receptor selectivity of dynorphin1–13 and related peptides
Wüster, M., Schulz, R., & Herz, A. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90237-2 · Cited by 52
Rasmussen, D. D., Kennedy, B. P., Ziegler, M. G., & Nett, T. M. (1988) · Endocrinology · doi:10.1210/endo-123-6-2916 · Cited by 52
Opiate receptors, food intake and obesity
Shimomura, Y., Oku, J., Glick, Z., & Bray, G. A. (1982) · Physiology & Behavior · doi:10.1016/0031-9384(82)90138-x · Cited by 51
Xu, J., Xu, M., Hurd, Y. L., Pasternak, G. W., & Pan, Y. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05833.x · Cited by 51
“Pharmacological studies have classified three families of opioid receptors, mu, delta and kappa (Martin et al. 1976; Lord et al. 1977; Pasternak 2004).”
BackgroundPeripheral receptors mediate the aversive conditioning effects of morphine in the rat
Bechara, A., Zito, K. A., & van der Kooy, D. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90218-8 · Cited by 57
Role of agonist-dependent receptor internalization in the regulation of μ opioid receptors
Sternini, C., Brecha, N. C., Minnis, J., D’Agostino, G., Balestra, B., Fiori, E., & Tonini, M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00118-4 · Cited by 51
Effect of opioids on acetylcholine release evoked by K+ or glutamic acid from rat neostriatal slices
Arenas, E., Alberch, J., Arroyos, R. S., & Marsal, J. (1990) · Brain Research · doi:10.1016/0006-8993(90)91633-r · Cited by 51
Radulović, J., Miljević, Č., Djergović, D., Vujić, V., Antić‐Stanković, J., von Hörsten, S., & Janković, B. D. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00161-g · Cited by 51
Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice
Brady, L. S., Herkenham, M. A., Rothman, R. B., Partilla, J. S., König, M., Zimmer, A. M., & Zimmer, A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00090-x · Cited by 51
Solubilization and Characterization of Opioid Binding Sites from Frog (Rana esculenta) Brain
Simon, J., Szűcs, M., Benyhe, S., Borsodi, A. D., Zeman, P., & Wollemann, M. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb12830.x · Cited by 51
Analgesia induced by intrathecal injection of dynorphin B in the rat
Han, J., Xie, G.-X., & D, A. G. M. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90612-x · Cited by 51
Are the endorphins active in clinical pain states? Narcotic antagonism in chronic pain patients
Lindblom, U., & Tegnér, R. (1979) · Pain · doi:10.1016/0304-3959(79)90107-6 · Cited by 51
Freye, E. C. K., Härtung, E., & Schenk, G. (1983) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03013801 · Cited by 51
The presence and actions of opioid receptors in bovine pineal gland
Govitrapong, P., Pariyanonth, M., & Ebadi, M. (1992) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1992.tb00066.x · Cited by 50
Structural studies of opioid peptides: A review of recent progress in x-ray diffraction studies
Deschamps, J. R., George, C. F., & Flippen-Anderson, J. L. (1996) · Biopolymers · doi:10.1002/bip.360400102 · Cited by 50
Porreca, F., Cowan, A., Raffa, R. B., & Tallarida, R. J. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90843-3 · Cited by 50
Neurons in the frontal cortex of the rat carry multiple opiate receptors
Williams, J. T., & Zieglga¨nsberger, W. (1981) · Brain Research · doi:10.1016/0006-8993(81)91103-3 · Cited by 50
Gouardères, C., Tellez, S., Tafani, J. A. M., & Zajac, J. (1993) · Synapse · doi:10.1002/syn.890130306 · Cited by 50
Hayes, A. G., Sheehan, M. J., & Tyers, M. B. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb11112.x · Cited by 50
Regulation of neuropeptide release
Iversen, L. L., Lee, C. M., Gilbert, R. F. T., Hunt, S. P., & Emson, P. C. (1980) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1980.0121 · Cited by 50
Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit
Jackisch, R., Geppert, M., Brenner, A. S., & Illés, P. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00511406 · Cited by 50
“The Ke-values for (--)naloxone and ( - ) M R 2266 were low and of the same order of magnitude: hence, they support the view that the inhibitory effects of ethylketocyclazocine are mediated by both ~- and #-receptors (Lord et al. 1977; Oka et al. 1982).”
Resultμ- and δ-opiate receptors: Correlation with high and low affinity opiate binding sites
Zhang, A.-Z., & Pasternak, G. W. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90518-x · Cited by 50
Specific in Vitro Uptake of Serotonin by Cells in the Anterior Pituitary of the Rat*
JOHNS, M. A., Azmitia, E. C., & Krieger, D. T. (1982) · Endocrinology · doi:10.1210/endo-110-3-754 · Cited by 50
Chemical crosslinking of a solubilized enkephalin macromolecular complex.
Zukin, R. S., & Kream, R. M. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.4.1593 · Cited by 50
Gintzler, A. R., & Liu, N. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.004 · Cited by 51
“Dyn has long been considered to be an endogenous KOR substrate (Chavkin and Goldstein, 1981a,b; Chavkin et al., 1982; Lord et al., 1977).”
Gatch, M. B., Negus, S. S., & Mello, N. K. (1998) · Psychopharmacology · doi:10.1007/s002130050490 · Cited by 52
Isolation and identification of an analgesic opioid dipeptide kyotorphin (TYR-ARG) from bovine brain
Shiomi, H., Ueda, H., & Takagi, H. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90109-x · Cited by 50
Young, G. A., & Khazan, N. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90233-8 · Cited by 49
Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide
Chiu, S., & Mishra, R. K. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90156-0 · Cited by 49
Pharmacology of spinal opioids
Sabbe, M. B., & Yaksh, T. L. (1990) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(90)90009-9 · Cited by 49
The Role of Glutamate in Physical Dependence on Opioids
Zhu, H., Rockhold, R. W., & Ho, I. K. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.76.1 · Cited by 50
Spetea, M., Monory, K., Tömböly, C., Tóth, G., Tzavara, E. T., Benyhe, S., Hanoune, J., & Borsodi, A. D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9395 · Cited by 49
Chesselet, M., Chéramy, A., Reisine, T., Lubetzki, C., Desban, M., & Glowinski, J. (1983) · Brain Research · doi:10.1016/0006-8993(83)91146-0 · Cited by 49
Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials
Buchsbaum, M. S., Davis, G. C., Naber, D., & Pickar, D. (1983) · Psychopharmacology · doi:10.1007/bf00427792 · Cited by 49
“In fact, in animal studies the most reliable opiate antagonist results occur in blocking stress-induced analgesia ( Lewis and Liebeskind 1980; Grau et al. 1981).”
BackgroundJenck, F., Quirion, R., & Wise, R. A. (1987) · Brain Research · doi:10.1016/0006-8993(87)90822-5 · Cited by 51
REVIEW ARTICLE: ACTH AND RELATED PEPTIDES
Donald, R. A. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02740.x · Cited by 53
The choice of opiate receptor subtype by neo-endorphins
Tetsuo, O. K. A., Negishi, K., Kajiwara, M., Watanabe, Y., Ishizuka, Y., & Matsumiya, T. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90636-7 · Cited by 49
FUDER, H., Buder, M., Riers, H. D., & Rothacher, G. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00511405 · Cited by 49
Blockade of endogenous opiates reduces activity in the rat
Walker, J. M., Berntson, G. G., Paulucci, T. S., & Champney, T. C. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90112-x · Cited by 49
The effect of medial hypothalamus lesions on pain control
Vidal, C., & Jacob, J. (1980) · Brain Research · doi:10.1016/0006-8993(80)90232-2 · Cited by 49
Is adenosine the mediator of opiate action on neuronal firing rate?
Stone, T. W., & Perkins, M. N. (1979) · Nature · doi:10.1038/281227a0 · Cited by 49
Shingu, K., Osawa, M., Omatsu, Y., Komatsu, T., Urabe, N., & Mori, K. (1981) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1981.tb01699.x · Cited by 49
Nadon, J., Rochon, K., Grastilleur, S., Langlois, G., Dao, T. T. H., Blais, V., Guérin, B., Gendron, L., & Dory, Y. L. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00163 · Cited by 48
Opioid Glycopeptide Analgesics Derived from Endogenous Enkephalins and Endorphins
Li, Y., Lefever, M. R., Dhanasekaran, M., Bidlack, J. M., Bilsky, E. J., & Polt, R. L. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.195 · Cited by 56
“The DOP receptor [15] was originally characterized using the mouse vas deferens smooth muscle tissue preparation (mouse vas deferens [MVD] assay) [16].”
MethodPain, nociception and spinal opioid receptors
Quirion, R. (1984) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(84)90017-4 · Cited by 52
Broccardo, M., Improta, G., & Tabacco, A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01470-2 · Cited by 48
Illéš, P., & N�renberg, W. (1990) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169034 · Cited by 48
Akil, H., Meng, F., Devine, D. P., & Watson, S. J. (1997) · Seminars in Neuroscience · doi:10.1006/smns.1997.0108 · Cited by 61
Suzuki, T., Mori, T., Tsuji, M., Maeda, J., Kishimoto, Y., Misawa, M., & Nagase, H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00062-9 · Cited by 48
The opioid receptors in the hamster vas deferens are of the δ-type
McKnight, A. T. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90184-4 · Cited by 48
Effects of pain, morphine and naloxone on the duration of animal hypnosis
Carli, G., Farabollini, F., & Fontani, G. (1981) · Behavioural Brain Research · doi:10.1016/0166-4328(81)90019-x · Cited by 49
Evans, R. G., Ludbrook, J., & Leeuwen, A. F. V. (1989) · The Journal of Physiology · doi:10.1113/jphysiol.1989.sp017858 · Cited by 48
Chahl, L. A. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00500014 · Cited by 48
“Morphine, endorphins and the enkephalins are all agonists at mu receptors in the guineapig ileum although enkephalins have been proposed to act on delta receptors in the mouse vas deferens and buprenorphine is a partial agonist at mu receptors (Martin et al. 1976; Lord et al. 1977; see Martin 1984).”
BackgroundNaloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin
Hazum, E., Chang, K., Cuatrecasas, P., & Pasternak, G. W. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90274-5 · Cited by 48
Giordano, J., & Barr, G. A. (1987) · Developmental Brain Research · doi:10.1016/0165-3806(87)90105-2 · Cited by 48
The effect of opiates on arterial baroreceptor reflex function in the rabbit
Petty, M. A., & Reid, J. L. (1982) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00495866 · Cited by 48
Effect of an Opiate Antagonist on Movement Disorders
Nutt, J. G., Rosin, A. J., Eisler, T., Calne, D. B., & Chase, T. N. (1978) · Archives of Neurology · doi:10.1001/archneur.1978.00500360034006 · Cited by 48
Subcellular distribution of enkephalin-dipeptidyl carboxypeptidase (enkephalinase) in rat brain
Baume, S. D. L., Patey, G., & Schwartz, J. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90125-1 · Cited by 48
Failure of naloxone to affect focal incomplete cerebral ischemia and collateral blood flow in cats
Hubbard, J. L., & Sundt, T. M. (1983) · Journal of neurosurgery · doi:10.3171/jns.1983.59.2.0237 · Cited by 47
Tiffany, S. T., Petrie, E. C., Baker, T. B., & Dahl, J. L. (1983) · Behavioral Neuroscience · doi:10.1037//0735-7044.97.3.335 · Cited by 49
Bremazocine: A κ‐Opioid Agonist with Potent Analgesic and Other Pharmacologic Properties
Dortch‐Carnes, J., & Potter, D. E. (2005) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00270.x · Cited by 47
Yuan, Y., Zaidi, S. A., Elbegdorj, O., Aschenbach, L. C., Guo, L., Stevens, D. L., Scoggins, K. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012214 · Cited by 48
Effects of morphine on brain plasticity
Campos, V., Silva-Vera, M., García-Campos, M. L., & Díaz-Cintra, S. Y. (2015) · Neurología (English Edition) · doi:10.1016/j.nrleng.2014.08.001 · Cited by 45
Efectos de la morfina en la plasticidad cerebral
Campos, V., Silva-Vera, M., García-Campos, M. L., & Díaz-Cintra, S. Y. (2014) · Neurología · doi:10.1016/j.nrl.2014.08.004 · Cited by 51
The Evolution of Fangs, Venom, and Mimicry Systems in Blenny Fishes
Casewell, N. R., Visser, J. C., Baumann, K., Dobson, J. S., Han, H., Kuruppu, S., Morgan, M., Romilio, A., Weisbecker, V., Mardon, K., et al. (2017) · Current Biology · doi:10.1016/j.cub.2017.02.067 · Cited by 47
“Proenkephalin encodes multiple 5-aa peptides known as met-enkephalins, which are endogenous opioid hormones that function by interacting with opioid receptors and induce transient analgesia, hypotension, and inflammatory responses [22–24].”
Dynorphin and its role in alcohol use disorder
Karkhanis, A. N., & Al-Hasani, R. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146742 · Cited by 47
“, 1976), as well as mu-, delta-, kappa-type action using in vitro bioassays (Lord et al., 1977).”
BackgroundClausen, K., Spatola, A. F., Lemieux, C., Schiller, P. W., & Lawesson, S.-O. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91449-9 · Cited by 47
Hucks, D., Thompson, P. I., McLoughlin, L., Joel, S. P., Patel, N. R., Grossman, A. B., REES, L. H., & Slevin, M. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.23 · Cited by 47
Suzuki, T., Tsuji, M., Mori, T., Misawa, M., Endoh, T., & Nagase, H. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00256-6 · Cited by 47
New glycosylpeptides with high antinociceptive activity
Rodrı́guez, R. E., Rodriguez, F. D., Sacristán, M. P., Torres, J. L., Valencia, G., & Antón, J. M. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90446-1 · Cited by 47
Endogenous ligands for κ-opiate receptors
Schulz, R., Wüster, M., & Herz, A. (1982) · Peptides · doi:10.1016/0196-9781(82)90067-5 · Cited by 47
Nijkamp, F. P., & van Ree, J. M. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb10849.x · Cited by 47
Specific activation of the μ opioid receptor (MOR) by endomorphin 1 and endomorphin 2
Monory, K., Bourin, M., Spetea, M., Tömböly, C., Tóth, G., Matthes, H. W. D., Kieffer, B. L., Hanoune, J., & Borsodi, A. D. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00936.x · Cited by 46
Molecular cloning and expression of a δ‐opioid recetpor from rat brain
Abood, M. E., Noel, M. A., Farnsworth, J., & Tao, Q. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370605 · Cited by 47
Interaction of naloxone with μ- and δ-opioid agonists on the respiration of rats
Pazos, Á., & Flórez, J. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90343-6 · Cited by 47
Differentiation of opiate receptors in the brain by the selective development of tolerance
Schulz, R., Wüster, M., & Herz, A. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90105-2 · Cited by 47
Recent Advances in Endomorphin Engineering
Keresztes, A., Borics, A., & Tóth, G. (2010) · ChemMedChem · doi:10.1002/cmdc.201000077 · Cited by 46
Metadata
- Authors
- Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W.
- Affiliations
- University of Aberdeen (GB)
- ORCID
- Lord, John A. H.
- Venue
- Nature
- Published
- 1977-06
- Volume
- 267
- Issue
- 5611
- Pages
- 495-499
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075811628
- Cited by
- 2,485
- References
- 27
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 11 · 2020: 42 · 2019: 18 · 2018: 13 · 2017: 13 · 2016: 7 · 2015: 22 · 2014: 21 · 2013: 29 · 2012: 34
- FWCI
- 35.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- endogenous opioids, opioid receptors, receptor agonists, naloxone binding, ileal smooth muscle contraction, vas deferens contraction, peptidergic systems
- MeSH terms
- Animals, Benzomorphans, Brain, Endorphins, Enkephalins, Guinea Pigs, Ileum, Male, Naloxone, Narcotic Antagonists, Narcotics, Oligopeptides, Peptides, Receptors, Opioid, Structure-Activity Relationship, Vas Deferens, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.